Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies

• Published in: International journal of molecular sciences 2022-02, Vol.23 (5), p.2496
• Main Authors: Wilczyński, Jacek R, Wilczyński, Miłosz, Paradowska, Edyta
• Format: Article
• Language: English
• Subjects: Ascites; Autophagy; Biology; cancer stem cells; Cancer therapies; Carcinoma, Ovarian Epithelial - pathology; Cell self-renewal; Chemotherapy; Clinical trials; Disease resistance; Drug dosages; Drug Resistance, Neoplasm; Epigenesis, Genetic; Epigenetics; Female; Gene expression; Genotype & phenotype; Glycoproteins; Health services; Humans; Hypoxia; Immunosuppressive agents; Immunosurveillance; Immunotherapy; Kinases; Laboratory animals; Medical prognosis; Metastasis; Mortality; Mutation; Neoplastic Stem Cells - metabolism; Organs; Ovarian cancer; ovarian cancer stem cells; Ovarian Neoplasms - genetics; Prognosis; Proteins; Review; Shear stress; Signal Transduction; Stem cells; therapy; Transcription factors; Transplants & implants; Tumor Microenvironment; Tumors
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23052496

Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance and recurrent disease are the main obstacles for successful therapy. One of the main reasons for this is the presence of a specific cell population of cancer stem cells. The aim of this review is to show the most contemporary knowledge concerning the biology of ovarian cancer stem cells (OCSCs) and their impact on chemo-resistance and prognosis in ovarian cancer patients, as well as to present the treatment options targeted exclusively on the OCSCs. The review presents data concerning the role of cancer stem cells in general and then concentrates on OCSCs. The surface and intracellular OCSCs markers and their meaning both for cancer biology and clinical prognosis, signaling pathways specifically activated in OCSCs, the genetic and epigenetic regulation of OCSCs function including the recent studies on the non-coding RNA regulation, cooperation between OCSCs and the tumor microenvironment (ovarian cancer niche) including very specific environment such as ascites fluid, the role of shear stress, autophagy and metabolic changes for the function of OCSCs, and finally mechanisms of OCSCs escape from immune surveillance, are described and discussed extensively. The possibilities of anti-OCSCs therapy both in experimental settings and in clinical trials are presented, including the recent II phase clinical trials and immunotherapy. OCSCs are a unique population of cancer cells showing a great plasticity, self-renewal potential and resistance against anti-cancer treatment. They are responsible for the progression and recurrence of the tumor. Several completed and ongoing clinical trials have tested different anti-OCSCs drugs which, however, have shown unsatisfactory efficacy in most cases. We propose a novel approach to ovarian cancer diagnosis and therapy.